John Connolly, PhD
Dr. Connolly designs and executes PICI’s overall research strategy in close collaboration with the institute’s leadership team, center directors and scientific steering committee. As a human immunologist, his research interests focus on immune monitoring and immunometabolism. Dr. Connolly previously served as CSO of Tessa Therapeutics, a clinical stage cell therapy company focused on solid tumor immunotherapy, and one of PICI’s strategic partners. He is an associate professor at National University of Singapore and an adjunct associate professor of Immunology at Baylor University.
